WEBULL
News
ALUR
0.300
-22.10%
-0.085
Weekly Report: what happened at ALUR last week (0302-0306)?
Weekly Report · 2d ago
8 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 03/03 12:05
Allurion Technologies Appeals NYSE Delisting, Plans Compliance Strategy
TipRanks · 03/02 16:02
Allurion Technologies to appeal NYSE notice of delisting
TipRanks · 03/02 14:25
Allurion Technologies Plans To Appeal NYSE's Delisting Decision
Benzinga · 03/02 14:07
Weekly Report: what happened at ALUR last week (0223-0227)?
Weekly Report · 03/02 10:18
Weekly Buzz: MGNX's LINNET Trial On Hold; ETON, ALUR Get FDA Nod; GILD Snaps Up ACLX
NASDAQ · 02/27 14:17
What's Going On With Allurion Stock On Wednesday?
Benzinga · 02/25 15:39
Allurion Technologies Amends Warrants to Bolster Liquidity
TipRanks · 02/25 14:00
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session
Benzinga · 02/24 21:06
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views
Benzinga · 02/24 17:38
3 Penny Stocks to Watch Now, 2/24/26
TipRanks · 02/24 15:01
Dow Gains Over 100 Points; Home Depot Posts Upbeat Earnings
Benzinga · 02/24 14:50
Allurion announces exercise of warrants for $3M in gross proceeds
Seeking Alpha · 02/24 14:27
Allurion Technologies Price Target Raised to $3.00/Share From $2.50 by Chardan Capital
Dow Jones · 02/24 14:22
Allurion Technologies Raised to Buy From Neutral by Chardan Capital
Dow Jones · 02/24 14:22
Allurion Technologies Announces $3M Warrant Exercise At $1.15 Per Share
Benzinga · 02/24 14:18
Chardan Capital Upgrades Allurion Technologies to Buy, Raises Price Target to $3
Benzinga · 02/24 14:12
Jefferies Sticks to Its Buy Rating for Allurion Technologies (ALUR)
TipRanks · 02/24 13:55
Allurion Technologies upgraded to Buy from Neutral at Chardan
TipRanks · 02/24 12:47
More
Webull provides a variety of real-time ALUR stock news. You can receive the latest news about ALLURION TECHNOLOGIES INC through multiple platforms. This information may help you make smarter investment decisions.
About ALUR
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.